CAN BE
ALTERNATIVE
INVESTMENT

NOT-TW-22-006
Brad Newsome, PhD
Opening date 7 Oct 2022, 12:00AM
Closing date N/A
Funding Opportunity Number: NOT-TW-22-006
Opportunity Category: Discretionary
Cost Sharing or Matching Requirement: No
Posted Date: Oct 07, 2022 12:00:00 AM EDT
Closing Date: N/A
Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification),Private institutions of higher education,Public and State controlled institutions of higher education,Native American tribal governments (Federally recognized),Native American tribal organizations (other than Federally recognized tribal governments),Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Description: The National Institutes of Health (NIH), in collaboration with the Global Alliance for Chronic Diseases (GACD), intends to publish a Funding Opportunity Announcement (FOA) to solicit applications for implementation research addressing risk factors for common noncommunicable diseases (NCDs) in low- and middle-income countries (LMICs) and American Indian/Alaska Native (AI/AN) populations in the United States (US). Chronic NCDs, such as diabetes, cardiovascular disease, neurological disorders and stroke, respiratory diseases, certain cancers, and mental health disorders are the leading cause of morbidity and mortality in both LMICs and high-income countries (HICs), especially within AI/AN populations in the United States. The COVID-19 pandemic has brought NCDs further into the spotlight, as the majority of those who have experienced severe illness and death have had one or more underlying NCDs. Reducing the burden of NCDs is therefore critical to building more resilient, equitable, and healthier societies. Air, water, and soil pollution; lack of greenspace; urban heat islands; lack of safe infrastructure for walking, cycling, and active living; and wide availability of tobacco, alcohol, and unhealthy foods and beverages drive the NCD epidemic in city environments. In the context of this FOA, "cities" include urban centers, informal settlements, slums, and periurban areas. More than half of the world�s population currently live in cities and this number is projected to rise to 68% by 2050. Recent climate related disasters, such as major flooding events, fires, and droughts, highlight how cities are at the forefront of the climate change crisis. There is an urgent need to equip local authorities and policymakers with strategies for maximizing the health-promoting potential of cities, while minimizing or reversing environmental degradation and health inequities. Fortunately, cities provide tremendous social, cultural, and economic opportunity, and have the potential to become engines of good health and support climate change adaptation. Innovative health-focused programs, policies, and infrastructure, such as public smoking bans, bikeable streets, greenspace, and vehicle emission laws, can shape the behaviors of millions of people and decrease exposure to environmental contaminants. City leaders are beginning to demonstrate a commitment to climate action, for example, through their participation in the C40 Cities network. This FOA intends to solicit applications that propose implementation research to reduce the risks of NCDs in the context of cities in LMICs and/or among AI/AN populations in US cities, with the potential to equip policymakers and practitioners with evidence-based strategies for prevention and/or management of NCDs among disadvantaged populations globally. NIH defines implementation research as the scientific study of the use of strategies to adopt and integrate evidence-based health interventions into clinical and community settings to improve individual outcomes and benefit population health. This FOA intends to support innovative approaches to identifying, understanding, developing, and implementing strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, tools, policies, and guidelines addressing NCD risk factors in city environments. In addition, studies to advance dissemination and implementation research methods and measures into application will be encouraged. Applicants to this FOA will be invited to conduct implementation research that leads to improved understanding of how specific interventions can be better adapted to different city environments and/or scaled within and across cities, considering unique local social, political, economic, and cultural contexts. Several behavioral change interventions, including those that increase the health-promoting potential of environments and decrease risks associated with unhealthy environments, are effective in reducing, delaying, or preventing the risk of NCD onset or disease progression. However, research is lacking in how to integrate such interventions into communities and health systems, and/or how to target these interventions within the context of the built environment and cities, especially in LMICs and within disadvantaged populations within US cities. Applicants responding to this FOA will be invited to meet this challenge. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.Applications will be accepted from US and LMIC institutions only. Eligible LMIC institutions are defined by the World Bank at the following link:datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups NIH partners plan to publish FOAs with the R01 (Clinical Trial Optional) and R61/R33 (Clinical Trial Required) activity codes in Fall 2022 with expected application due dates in Winter/Spring 2023. Historically, the following NIH ICs have participated in GACD-associated FOAs and are anticipated to continue this participation: National Cancer Institute (NCI); National Eye Institute (NEI); National Heart, Lung, and Blood Institute (NHLBI); National Institute on Aging (NIA); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute on Drug Abuse (NIDA); National Institute of Environmental Health Sciences (NIEHS); National Institute of Mental Health (NIMH); National Institute on Minority Health and Health Disparities (NIMHD); and National Institute of Neurological Disorders and Stroke (NINDS).
Value Ad helps new businesses save 50% to 80% on essential services like marketing and
development. These savings act as an alternative investment, fueling growth.
Service providers gain valuable initial customers, helping them grow and attract investment.
It's a win-win for everyone!
This App/website is not affiliated with any government agency. We collect and organize information from publicly available government websites and provide direct links to these official sources.
For accurate details and to apply for grants or loans, please visit the relevant government websites linked within the App/website.
What is Value Ad?
Value Ad is an innovative policy designed to foster a mutually beneficial relationship between two key groups: new businesses and service providers. This policy helps startups save significantly on essential services while enabling service providers to gain valuable traction and growth opportunities.
How is it a Win-Win Deal?
For New Businesses:
Cost Savings: Startups can save 50% to 80% on essential services such as website development and marketing. This means they don’t need to invest heavily upfront, making it easier to launch and grow their business.
Alternative Investment: The money saved through these discounts can be reinvested into other critical areas of the business, acting as an alternative investment that fuels further growth and development.
For Service Providers:
Initial Customer Base: Service providers, often tech startups themselves, can attract a significant number of initial customers by offering their services at a discounted rate. This helps them build traction and demonstrate value, which is crucial for attracting venture capital (VC) funding and other opportunities.
Marketing Efficiency: By providing affordable services, service providers do not need to spend heavily on marketing to acquire new customers. The discounted services themselves become a powerful marketing tool, bringing in customers who can spread the word and enhance the provider’s reputation.
Growth and Expansion: Attracting more customers through Value Ad helps service providers expand their client base and build long-term relationships, which can lead to increased revenue and business growth.
Alternative Investment for New Businesses:
For new businesses, the significant cost savings achieved through the Value Ad policy effectively serve as an alternative investment. Instead of spending large amounts on website development and marketing, they can leverage the affordable services provided by service providers. The saved funds can be redirected into other strategic areas of the business, enhancing overall growth and sustainability.
Benefits for Service Providers:
Service providers benefit from the Value Ad policy by gaining access to a ready pool of new customers who are drawn by the discounted rates. This initial customer base is crucial for:
Building Traction: Demonstrating product or service viability to potential investors.
Securing Funding: Enhanced customer traction and a growing user base can make the service provider more attractive to venture capitalists and other funding sources.
Market Penetration: Establishing a presence in the market quickly and efficiently without heavy marketing expenditures.
In Summary:
Value Ad is a strategic policy designed to create a win-win scenario for both new businesses and service providers. By offering significant discounts on essential services, startups can save and reinvest those savings, while service providers gain crucial initial customers and market traction. This mutually beneficial arrangement supports the growth and success of both groups, making Value Ad a powerful tool for business development and investment.
We use cookies and similar technologies that are necessary to operate the website.Please read our cookie policy.
We use cookies and similar technologies that are necessary to operate the website. Additional cookies are only used with your consent. We use the additional cookies to perform analyses of website usage and to check marketing measures for their efficiency. These analyses are carried out to provide you with a better user experience on the website. You are free to give, deny, or withdraw your consent at any time by using the "cookie settings" link at the bottom of each page. You can consent to our use of cookies by clicking "Agree". For more information about what information is collected and how it is shared with our partners, please read our cookie policy.